Partnership combines world-class protein engineering with scalable drug development to accelerate innovationBOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a leading biotechnology ecosystem company, ...

Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization of AMC Health's DCT platform NEW YORK CITY, NY / ACCESS ...

Revenue of $711 million; pro forma revenue of $687 million; 7% revenue growth; 3% organic growth; 6% pro forma organic ...

Advanced Health Announces Grand Opening and Community Blood Drive with The Blood Connection on May 19 GREENVILLE, SC / ACCESS Newswire / May 5, 2026 / Advanced Health will host a community open house ...

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forumMeeting co-hosted with MIT leadership: Sally ...

NEW YORK CITY, NY / ACCESS Newswire / May 5, 2026 / AI Maverick Intel, Inc. ("AIMV" or the "Company") is providing an update ...

The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: ...

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the Abhijit Zutshi as Chief Commercial Officer (CCO) and Maninder Kapoor Puri as ...

UCB, a global biopharmaceutical company, today (May 3rd) announced signing of a definitive agreement under which it would ...

"You cannot responsibly introduce products into a Medicare population when their chemistry is not fully defined and their safety cannot be established. This is not a policy debate-it's a scientific ...

Ceva Animal Health (Ceva), the world’s fifth largest animal health company, present in 110 countries, today announces the appointment of Ian Tarpey as EVP, Group Innovation and R&D Director, and a new ...

Scottish green chemical producer has received a share of £7 million to help overcome the barriers to bio‑based solvent production and uptake in the pharmaceutical industry. (Links to accompanying ...